Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?
The purpose of this study was to try to determine by means of contrast-enhanced MRI, a subset of patients with Graves' ophthalmopathy who will not respond to orbital radiotherapy. 54 patients with Graves' ophthalmopathy were treated with orbital radiotherapy (10 x 2 Gy) and symptom relief was recorded. MRI examinations prior to radiotherapy were retrospectively evaluated for enlargement, contrast enhancement and fibrotic changes in extraocular muscles and surrounding soft tissue. Imaging data were correlated with clinical features and response. Symptom relief was observed in 61% of patients but this could not be predicted by any of the MRI signs investigated. However, there is a trend for a better treatment reponse in patients who show contrast enhancement of extraocular muscles prior to orbital radiotherapy (p=0.08). MRI could not adequately predict the efficacy of orbital radiotherapy in this group of patients. Clinical assessment of disease activity is still the most reliable method.
Ott
M
M
Departments of Radiotherapy and Neuroradiology, University Hospital, 37075 Göttingen, Germany.
Breiter
N
N
Albrecht
C F
CF
Pradier
O
O
Hess
C F
CF
Schmidberger
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005682:Gadolinium; D006111:Graves Disease / Q000175:diagnosis / Q000532:radiotherapy*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009915:Orbit; D018579:Patient Selection; D012189:Retrospective Studies; D016896:Treatment Outcome
D005682:Gadolinium